2 ms·
The issues described (or rather, the lack of knowledge that is at the bottom of these issues) are not new, they are true for many, many forms of medicine we use
by mschuster91 5y ago
The issues described (or rather, the lack of knowledge that is at the bottom of these issues) are not new, they are true for many, many forms of medicine we use today. ffs we don't even know how exactly virtually all medicine used in treatment of mental illnesses such as schizophrenia and depression work - most medical treatments consist of trying all available candidates and varying the dosage until you find a somewhat effective one - and yet we accept this lack of knowledge.
As for what this means for vaccines: It is by now widely accepted that a vaccination drastically reduces the effects of a COVID19 infection and all but eliminates the risk of fatal outcomes and that in billions of people vaccinated by billions of doses of various vaccines the side effects were negligibly small, and it is widely accepted that even in young healthy people, COVID19 can cause severe, even long-term cases. Therefore, the potential risks of vaccination are nowhere near as risky as risking the infection with the actual pathogen.
- LurkingPenguin 5y ago> As for what this means for vaccines: It is by now widely accepted that a vaccination drastically reduces the effects of a COVID19 infection and all but eliminates the risk of fatal outcomes and that in billions of people vaccinated by billions of doses of various vaccines the side effects were negligibly small, and it is widely accepted that even in young healthy people, COVID19 can cause severe, even long-term cases. Therefore, the potential risks of vaccination are nowhere near as risky as risking the infection with the actual pathogen. The vaccination discussion you're trying to have has already been settled. The panel was not revisiting the approved 2-dose course. It was considering the benefits and risks of a third (booster) jab for individuals aged 16 and above. If you had listened to the panel, you'd understand the vote: there is not enough data at this time to conclude that the benefits outweigh the risks for a booster in such a broad group.